These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18581185)

  • 1. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
    Chen J; Tward JD; Shrieve DC; Hitchcock YJ
    Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
    Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
    Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
    Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
    Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
    Heron DE; Karimpour S; Grigsby PW
    Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
    Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
    G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
    McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
    Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.
    Veness MJ; Porter GS; Morgan GJ
    ANZ J Surg; 2004 Jul; 74(7):559-62. PubMed ID: 15230790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
    Junor EJ; Paul J; Reed NS
    Eur J Surg Oncol; 1992 Apr; 18(2):83-8. PubMed ID: 1582515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of anaplastic thyroid carcinoma.
    Kihara M; Miyauchi A; Yamauchi A; Yokomise H
    Surg Today; 2004; 34(5):394-8. PubMed ID: 15108075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and prognosis of anaplastic thyroid carcinoma].
    Sun CZ; Chen FJ; Zeng ZY; Chen YF; Li QL; Guan Z; Tian SZ
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1493-7. PubMed ID: 17349179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis.
    Dandekar P; Harmer C; Barbachano Y; Rhys-Evans P; Harrington K; Nutting C; Newbold K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):518-21. PubMed ID: 19395202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
    Sugitani I; Kasai N; Fujimoto Y; Yanagisawa A
    World J Surg; 2001 May; 25(5):617-22. PubMed ID: 11369989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.